Dr Melanie Grandits

Melanie Grandits has received her BSc in Chemistry and MSc in Biotechnology and Bioanalytics from Vienna University of Technology. She did her PhD under the supervision of Prof Julian Ma at St George's University of London, focusing on the expression and characterisation of plant made anti-HIV antibodies with enhanced efficacy and glycoengineering using CRISPR/Cas9. She has joined the Cancer Antibody Discovery & Immunotherapy Group at King's College London in 2020 as Postdoctoral Research Associate.